| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 10/07/2003 | CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays |
| 10/02/2003 | WO2003080094A1 Product for regression of tumors occuring in the human body |
| 10/02/2003 | WO2003080093A1 A process for the preparation of a new medicinal combination for regression of intracranial tumors and other tumors occurring in the human body |
| 10/02/2003 | WO2003079966A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 10/02/2003 | US20030186390 Detecting or determining transfer of nucleotide sequences via gene expression or reporter molecule expression analysis in transformed cells |
| 10/02/2003 | US20030185834 Administering an anti-angiogenesis factor to localize in the choroidal neovasculature; administering photosensitizer; photodynamic therapy by irradiating with laser light |
| 10/02/2003 | US20030185804 Compounds for the photodecontamination of pathogens in blood |
| 10/02/2003 | US20030185756 Carbocyanine dye for visualization, photosensitizer for photodynamic treatment, and tumor receptor-avid peptide for site-specific delivery of the probe and phototoxic agent to diseased tissues |
| 10/01/2003 | EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 10/01/2003 | EP1094843B1 Targeted site specific drug delivery compositions and uses |
| 10/01/2003 | EP1089788B1 Sonophoresis apparatus |
| 10/01/2003 | CN1123050C Method of improving skin condition |
| 09/30/2003 | US6627664 Administering perylenequinone derivative, and activating the derivative by exposing the perylenequinone to sound of a pre-determined frequency for therapy |
| 09/25/2003 | WO2003078361A1 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 09/25/2003 | WO2003077933A1 Increasing tumor oxygen content by administration of stressed cells |
| 09/25/2003 | WO2003077873A2 Photosensitizers for photodynamic therapy of microbial infections |
| 09/25/2003 | WO2003077723A2 Methods and devices for detection and therapy of atheromatous plaque |
| 09/25/2003 | WO2002036161A3 Novel targeted compositions for diagnostic and therapeutic use |
| 09/25/2003 | US20030181847 For topical treatment of nail diseases (onychomycosis) after forming aperture in infected nail with laser beam; fungicides (terbinafine) |
| 09/25/2003 | US20030181377 Inhibition of VEGF receptor signaling reverses tumor resistance to radiotherapy |
| 09/25/2003 | US20030180370 Iron oxide core with overcoating shell; antitumor agents |
| 09/25/2003 | US20030180292 Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy |
| 09/25/2003 | US20030180291 Method of inactivating viruses |
| 09/25/2003 | US20030180224 Photosensitisers |
| 09/25/2003 | CA2478805A1 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 09/25/2003 | CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1345606A2 Texaphyrin coordination compounds and uses thereof |
| 09/23/2003 | US6623513 Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin |
| 09/20/2003 | CA2377442A1 Increasing tumor oxygen content by administration of stressed cells |
| 09/18/2003 | WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer |
| 09/18/2003 | WO2003057259A3 Indocyanine green (icg) compositions |
| 09/18/2003 | WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 09/18/2003 | US20030176438 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2003 | US20030176389 Administering to a subject suffering from gastrointestinal inflammation a formulation comprising an immunomodulatory nucleic acid to the subject, the immunomodulatory nucleic acid comprising the sequence 5'-CpG-3' |
| 09/18/2003 | US20030176326 For therapy and prophylaxis of infectious diseases due to pathogenic microorganisms |
| 09/18/2003 | US20030176320 For therapy of cancer, autoimmune diseases and restenosis; efficiency |
| 09/18/2003 | US20030175356 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 09/18/2003 | US20030175282 Photodynamic therapy comprising administering angiogenesis factor antagonists and photosensitizers then irradiating with lasers, for prophylaxis of vision defects |
| 09/18/2003 | US20030175245 Replication deficient adenoviral TNF vector |
| 09/17/2003 | CN1121217C Immunological compound |
| 09/16/2003 | US6620929 1,3-Dipolar cycloadditions to polypyrrolic macrocycles |
| 09/16/2003 | US6620382 Method and compositions for treatment of cancers |
| 09/12/2003 | WO2003074002A2 Methods of treating pin1 associated disorders |
| 09/12/2003 | WO2003039596B1 Photodynamic therapy for the treatment of hair loss |
| 09/11/2003 | US20030170430 Portable bio-wave device including a bio-wave card and a sticky piece that can enhance immunity of the human body when attached to an ache part of the user |
| 09/11/2003 | US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood |
| 09/11/2003 | US20030170177 Useful as vehicle for gene therapy, and in imaging |
| 09/10/2003 | EP1342728A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity |
| 09/10/2003 | CN1440813A Physical prepn product for electronic regulation in gene molecular engineering |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/04/2003 | WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | WO2003071953A1 Photodynamic diagnosis of oral cancer |
| 09/04/2003 | WO2003063902A3 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers |
| 09/04/2003 | US20030167033 Systems and methods for photodynamic therapy |
| 09/04/2003 | US20030167023 Ultrasound catheter for providing a therapeutic effect to a vessel of a body |
| 09/04/2003 | US20030167006 Ultrasound contrast using halogenated xanthenes |
| 09/04/2003 | US20030166727 Antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity |
| 09/04/2003 | US20030166617 Combination therapies with vascular damaging activity |
| 09/04/2003 | US20030166591 Testosterone-repressed prostate message-2 (TRPM-2); gene expression inhibition; increased antitumor activity |
| 09/04/2003 | US20030166507 Water soluble paclitaxel derivatives |
| 09/04/2003 | US20030165475 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 09/04/2003 | US20030165432 Versatile hydrophilic dyes |
| 09/04/2003 | US20030165426 Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy |
| 09/04/2003 | CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/03/2003 | EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 09/03/2003 | EP1250339B1 Porphyrins and related compounds |
| 09/03/2003 | CN1440297A photodynamic treatment and UV-B irradiation of thrombocyte suspension |
| 09/03/2003 | CN1120166C New class of benzoporphyrin derivative photoactive compounds |
| 09/02/2003 | US6613751 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 09/02/2003 | US6613305 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 08/28/2003 | WO2003070933A2 Process of cell electrofusion |
| 08/28/2003 | WO2003070905A2 Electroporation methods for introducing bioactive agents into cells |
| 08/28/2003 | WO2003070890A2 THE p65 SUBUNIT OF NF-κB FOR THE RADIOSENSITIZATION OF CELLS |
| 08/28/2003 | WO2003070726A1 Pyranones useful as atm inhibitors |
| 08/28/2003 | WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2003 | US20030162963 Novel expanded porphyrins and process for the synthesis thereof |
| 08/28/2003 | US20030162826 Degradation fragments |
| 08/28/2003 | US20030162750 Lyophilizate of lipid complex of water insoluble porphyrins |
| 08/28/2003 | US20030162198 Medical diagnosis; complexing to Dna; calibration |
| 08/28/2003 | US20030162124 Compound which performs non-resonant two-photon absorption, non-resonant two-photon light-emitting compound and non-resonant two-photon absorption induction method and process for emitting light thereby, optical data recording medium and process for recording data thereon, and two-photon polymerizable composition and process for polymerization thereof |
| 08/28/2003 | US20030161811 Method for treating cervical cancer |
| 08/28/2003 | CA2476452A1 Electroporation methods for introducing bioactive agents into cells |
| 08/28/2003 | CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2003 | CA2473100A1 Pyranones useful as atm inhibitors |
| 08/27/2003 | EP1033972B1 Drug delivery system with two-step targeting |
| 08/27/2003 | CN1119173C Methods for preparing gas-filled liposomes |
| 08/26/2003 | US6610722 Inhibitors of prenyl-protein transferase |
| 08/26/2003 | US6610679 Use of green porphyrins to treat neovasculature in the eye |
| 08/26/2003 | US6610298 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell. |
| 08/26/2003 | US6610044 Method for genetic immunization |
| 08/21/2003 | WO2003068929A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 08/21/2003 | WO2003068155A2 Inhibition of vegf receptor signaling reverses tumor resistance to radiotherapy |
| 08/21/2003 | WO2003026481A3 Optically-absorbing nanoparticles for enhanced tissue repair |
| 08/21/2003 | WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury |
| 08/21/2003 | US20030158258 5-aminolevulinic acid ester solution; detection of fluorescent protoporphyrin IX |
| 08/21/2003 | US20030158127 Aromatic sulfenates for type I phototherapy |
| 08/21/2003 | US20030157104 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |